Pfizer Inc (PFE)
25.65
+0.52
(+2.07%)
USD |
NYSE |
Nov 22, 16:00
25.60
-0.05
(-0.19%)
Pre-Market: 20:00
Pfizer Price to Book Value: 1.575 for Nov. 22, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 1.575 |
| November 21, 2024 | 1.543 |
| November 20, 2024 | 1.532 |
| November 19, 2024 | 1.541 |
| November 18, 2024 | 1.527 |
| November 15, 2024 | 1.523 |
| November 14, 2024 | 1.598 |
| November 13, 2024 | 1.641 |
| November 12, 2024 | 1.608 |
| November 11, 2024 | 1.611 |
| November 08, 2024 | 1.641 |
| November 07, 2024 | 1.686 |
| November 06, 2024 | 1.680 |
| November 05, 2024 | 1.719 |
| November 04, 2024 | 1.705 |
| November 01, 2024 | 1.725 |
| October 31, 2024 | 1.738 |
| October 30, 2024 | 1.751 |
| October 29, 2024 | 1.747 |
| October 28, 2024 | 1.772 |
| October 25, 2024 | 1.747 |
| October 24, 2024 | 1.758 |
| October 23, 2024 | 1.772 |
| October 22, 2024 | 1.771 |
| October 21, 2024 | 1.776 |
| Date | Value |
|---|---|
| October 18, 2024 | 1.794 |
| October 17, 2024 | 1.797 |
| October 16, 2024 | 1.822 |
| October 15, 2024 | 1.808 |
| October 14, 2024 | 1.785 |
| October 11, 2024 | 1.790 |
| October 10, 2024 | 1.801 |
| October 09, 2024 | 1.854 |
| October 08, 2024 | 1.792 |
| October 07, 2024 | 1.793 |
| October 04, 2024 | 1.755 |
| October 03, 2024 | 1.74 |
| October 02, 2024 | 1.756 |
| October 01, 2024 | 1.760 |
| September 30, 2024 | 1.777 |
| September 27, 2024 | 1.880 |
| September 26, 2024 | 1.872 |
| September 25, 2024 | 1.869 |
| September 24, 2024 | 1.906 |
| September 23, 2024 | 1.894 |
| September 20, 2024 | 1.901 |
| September 19, 2024 | 1.916 |
| September 18, 2024 | 1.922 |
| September 17, 2024 | 1.928 |
| September 16, 2024 | 1.943 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.522
Minimum
Dec 14 2023
4.542
Maximum
Dec 16 2021
2.746
Average
2.962
Median
Price to Book Value Benchmarks
| Amgen Inc | 21.03 |
| Johnson & Johnson | 5.325 |
| Eli Lilly and Co | 49.87 |
| Merck & Co Inc | 5.638 |
| Moderna Inc | 1.326 |
Price to Book Value Related Metrics
| PE Ratio | 34.66 |
| PS Ratio | 2.456 |
| Price to Free Cash Flow | 17.73 |
| Price | 25.65 |
| Earnings Yield | 2.88% |
| Market Cap | 145.36B |
| Operating PE Ratio | 16.13 |
| Normalized PE Ratio | 16.52 |